Cited by 751Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Mackie, K.·2005·Handbook of Experimental Pharmacology

DOI 10.1007/3-540-26573-2_10

Open this paper in CoChat — free account

Abstract

CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.

Integrity signals

Registry

Crossref · 10.1007/3-540-26573-2_10

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citation
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citation
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085

Show all 103 references

Research works printed but not linked: 1

Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466

Sorted by citations

Items 101–200 of 751

Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells
Soethoudt, M., Stolze, S. C., Westphal, M. V., van Stralen, L., Martella, A., van Rooden, E. J., Guba, W., Varga, Z. V., Deng, H., van Kasteren, S. I., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11281 · Cited by 80
Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors
Bian, Y., Wang, J., Jun, J. J., & Xie, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00500 · Cited by 80
Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ramesh, R. G., Watts, J. J., & Mizrahi, R. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110096 · Cited by 83
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
Cohen, J. L., Jorizzo, J. L., & Kircik, L. (2007) · PubMed · Cited by 79
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.626010 · Cited by 81
Mouse and rat ultrasonic vocalizations in neuroscience and neuropharmacology: State of the art and future applications
Premoli, M., Pietropaolo, S., Wöhr, M., Simola, N., & Bonini, S. A. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15957 · Cited by 83
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
Dzierżanowski, T. (2019) · Cancers · doi:10.3390/cancers11020129 · Cited by 79
Dynamic changes of CB1‐receptor expression in hippocampi of epileptic mice and humans
Maglóczky, Z., Tóth, K., Karlócai, M. R., Nagy, S., Erőss, L., Czirják, S., Vajda, J., Rásonyi, G., Kelemen, A., Juhos, V., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02624.x · Cited by 77
Self-citation
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108394 · Cited by 78
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Seltzman, H. H., Shiner, C., Hirt, E. E., Gilliam, A. F., Thomas, B. F., Maitra, R., Snyder, R. W., Black, S. R., Patel, P. R., Mulpuri, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00516 · Cited by 75
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
Petrucci, V., Chicca, A., Glasmacher, S., Pálóczi, J., Cao, Z., Pacher, P., & Gertsch, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09808-8 · Cited by 75
Cannabinoid receptor type-1: breaking the dogmas
Busquets-García, A., Gómez, E. S., Bellocchio, L., & Marsicano, G. (2016) · F1000Research · doi:10.12688/f1000research.8245.1 · Cited by 79
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
Dı́ez-Alarcia, R., Ibarra‐Lecue, I., López‐Cardona, A. P., Meana, J. J., Gutiérrez‐Adán, A., Callado, L. F., Agirregoitia, E., & Urigüen, L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00415 · Cited by 73
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Kuhns, L., Kroon, E., Colyer‐Patel, K., & Cousijn, J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06001-8 · Cited by 73
The Role of Cannabinoids in Regulation of Nausea and Vomiting, and Visceral Pain
Malik, Z. A., Baik, D. A., & Schey, R. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0429-1 · Cited by 72
CB1 cannabinoid receptor-mediated aggressive behavior
Rodríguez‐Arias, M., Navarrete, F., Daza‐Losada, M., Navarro, D., Aguilar, M. A., Berbel, P. J., Miñarro, J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.013 · Cited by 72
Safety Considerations in Cannabinoid-Based Medicine
Gottschling, S., Ayonrinde, O., Bhaskar, A., Blockman, M., D’Agnone, O., Schecter, D., Rodríguez, L. D. S., Yafai, S., & Cyr, C. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s275049 · Cited by 72
Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion
López‐Gallardo, M., López-Rodríguez, A. B., Llorente‐Berzal, A., Rotllant, D., Mackie, K., Armario, A., Nadal, R. A., & Viveros, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.063 · Cited by 73
Self-citation
Neuronal populations mediating the effects of endocannabinoids on stress and emotionality
Häring, M., Guggenhuber, S., & Lutz, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.035 · Cited by 72
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy
Karlócai, M. R., Tóth, K., Watanabe, M., Ledent, C. A., Juhász, G. D., Freund, T. F., & Maglóczky, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027196 · Cited by 69
Should Cannabinoids Be Added to Multimodal Pain Regimens After Total Hip and Knee Arthroplasty?
Hickernell, T. R., Lakra, A., Berg, A. R., Cooper, H. J., Geller, J. A., & Shah, R. P. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.07.027 · Cited by 68
Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
Milligan, A. L., Szabo-Pardi, T. A., & Burton, M. D. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1668100 · Cited by 70
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
Flores, Á., Maldonado, R. J., & Berrendero, F. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00256 · Cited by 74
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Grabon, W., Rheims, S., Smith, J., Bodennec, J., Belmeguenaï, A., & Bezin, L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105226 · Cited by 67
Cannabinoids and hamster circadian activity rhythms
Sanford, A. E., Castillo, E., & Gannon, R. L. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.048 · Cited by 67
Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons
Veress, G., Mészár, Z., Muszil, D., Avelino, A., Matesz, K., Mackie, K., & Nagy, I. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0425-2 · Cited by 67
Self-citation
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Spiller, K. J., Bi, G., He, Y., Galaj, E., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14625 · Cited by 67
Cognitive function as an emerging treatment target for marijuana addiction.
Sofuoglu, M., Sugarman, D. E., & Carroll, K. M. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0019295 · Cited by 66
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice
Han, X., He, Y., Bi, G., Zhang, H., Song, R., Liu, Q., Egan, J. M., Gardner, E. L., Li, J., & Xi, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-12399-z · Cited by 66
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Galaj, E., & Xi, Z. (2019) · CNS Drugs · doi:10.1007/s40263-019-00664-w · Cited by 69
Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults
Shollenbarger, S. G., Price, J., Wieser, J., & Lisdahl, K. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.03.024 · Cited by 64
The genetic basis of the endocannabinoid system and drug addiction in humans
López‐Moreno, J. A., Echeverry‐Alzate, V., & Bühler, K. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111416689 · Cited by 64
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor
Slavik, R., Herde, A. M., Bieri, D., Weber, M., Schibli, R., Krämer, S. D., Ametamey, S. M., & Mu, L. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.028 · Cited by 64
Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants
Lichenstein, S. D., Manco, N., Cope, L. M., Egbo, L., Garrison, K. A., Hardee, J., Hillmer, A. T., Reeder, K., Stern, E. F., Worhunsky, P., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01226-9 · Cited by 63
Cannabinoid use and self-injurious behaviours: A systematic review and meta-analysis
Escelsior, A., Murri, M. B., Corsini, G. P., Serafini, G., Aguglia, A., Zampogna, D., Cattedra, S., Nebbia, J., Trabucco, A., Prestía, D., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.020 · Cited by 64
Whole-brain activation signatures of weight-lowering drugs
Hansen, H. H., Perens, J., Roostalu, U., Skytte, J. L., Salinas, C. G., Barkholt, P., Thorbek, D. D., Rigbolt, K. T. G., Vrang, N., Jelsing, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101171 · Cited by 65
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Liu, C. S., Chau, S. A., Ruthirakuhan, M. T., Lanctôt, K. L., & Herrmann, N. (2015) · CNS Drugs · doi:10.1007/s40263-015-0270-y · Cited by 63
Endocannabinoid signaling in social functioning: an RDoC perspective
Karhson, D. S., Hardan, A. Y., & Parker, K. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.169 · Cited by 62
The neuropharmacology of cannabinoid receptor ligands in central signaling pathways
Brunt, T. M., & Bossong, M. G. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14982 · Cited by 67
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Henson, J. D., Vitetta, L., & Hall, S. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01020-z · Cited by 62
Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memoryPreprint
Alvares, L. D. O., Engelke, D. S., Diehl, F., Scheffer-Teixeira, R., Haubrich, J., Cassini, L. F., Molina, V. A., & Quillfeldt, J. A. (2010) · Learning & Memory · doi:10.1101/lm.1721010 · Cited by 61
Advancing the science on cannabis concentrates and behavioural health
Bidwell, L. C., Martin‐Willett, R., & Karoly, H. C. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13281 · Cited by 60
Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
Scherma, M., Dessì, C., Muntoni, A. L., Lecca, S., Satta, V., Luchicchi, A., Pistis, M., Panlilio, L. V., Fattore, L., Goldberg, S. R., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.295 · Cited by 61
β-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-γ and regulates Mφ1/Mφ2 balances
Askari, V. R., Fereydouni, N., Rahimi, V. B., Askari, N., Sahebkar, A. H., Rahmanian‐Devin, P., & Samzadeh‐Kermani, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.098 · Cited by 59
Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism
Hosie, S., Malone, D. T., Liu, S., Glass, M., Adlard, P. A., Hannan, A. J., & Hill‐Yardin, E. L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00234 · Cited by 60
Cannabinoid modulation of limbic forebrain noradrenergic circuitry
Carvalho, A. F., Mackie, K., & Bockstaele, E. J. V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07054.x · Cited by 58
Self-citation
Framework for sex differences in adolescent neurobiology: A focus on cannabinoids
Viveros, M., Marco, E. M., López‐Gallardo, M., García‐Segura, L. M., & Wagner, E. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.005 · Cited by 59
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists
Patel, M., Manning, J. J., Finlay, D. B., Javitch, J. A., Banister, S. D., Grimsey, N. L., & Glass, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113871 · Cited by 57
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
Martinez, A. A., Macheda, T., Morgese, M. G., Trabace, L., & Giuffrida, A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.12.006 · Cited by 57
Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1
Crespo, I., de Heras, R. G., de Fonseca, F. R., & Navarro, M. A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.027 · Cited by 57
CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus
Bequet, F., Uzabiaga, F., Desbazeille, M., Ludwiczak, P., Maftouh, M., Picard, C., Scatton, B., & Fur, G. L. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05900.x · Cited by 56
A translational perspective on neural circuits of fear extinction: Current promises and challenges
Sevenster, D., Visser, R. M., & D’Hooge, R. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.07.002 · Cited by 64
Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
Sharafi, G., He, H. Z., & Nikfarjam, M. (2019) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2018.0019 · Cited by 56
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 56
The Endocannabinoid 2-Arachidonoyl-Glycerol Controls Odor Sensitivity in Larvae of Xenopus laevis
Breunig, E., Manzini, I., Piscitelli, F., Gutermann, B., Marzo, V. D., Schild, D., & Czesnik, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4030-09.2010 · Cited by 56
Disturbances of postural sway components in cannabis users
Bolbecker, A. R., Apthorp, D., Martin, A. M. S., Tahayori, B., Moravec, L., Gomez, K. L., O’Donnell, B. F., Newman, S. D., & Hetrick, W. P. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.012 · Cited by 55
The Cannabinoids Effect on Bone Formation and Bone Healing
Raphael-Mizrahi, B., & Gabet, Y. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00607-1 · Cited by 57
Analysis of the effects of cannabinoids on identified synaptic connections in the caudate‐putamen by paired recordings in transgenic mice
Freiman, I., Anton, A., Monyer, H., Urbanski, M. J., & Szabó, B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114272 · Cited by 55
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
Nigro, E., Formato, M., Crescente, G., & Daniele, A. (2021) · Molecules · doi:10.3390/molecules26092668 · Cited by 54
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images
Ballard, M. E., Bedi, G., & de Wit, H. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112446530 · Cited by 60
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
van Winkel, R., & Kuepper, R. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153631 · Cited by 56
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission
Lee, S.-H., Dudok, B., Parihar, V. K., Jung, K., Zöldi, M., Kang, Y., Maroso, M., Alexander, A., Nelson, G. A., Piomelli, D., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1345-3 · Cited by 54
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System
Gertsch, J. (2008) · Planta Medica · doi:10.1055/s-2008-1034302 · Cited by 54
Striatal CB 1 and D2 receptors regulate expression of each other, CRIP 1A and delta opioid systems
Blume, L. C., Bass, C. E., Childers, S. R., Dalton, G. D., Roberts, D. C. S., Richardson, J. M., Xiao, R., Selley, D. E., & Howlett, A. C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12139 · Cited by 52
RETRACTED ARTICLE: Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors
Pietrzak, R. H., Huang, Y. H., Corsi-Travali, S., Zheng, M., Lin, S.-F., Henry, S. E., Potenza, M. N., Piomelli, D., Carson, R. E., & Neumeister, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.110 · Cited by 55
Retracted
Multiple mechanisms of microglia: A gatekeeper's contribution to pain states
Graeber, M. B., & Christie, M. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.007 · Cited by 51
The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults
Lisdahl, K. M., Tamm, L., Epstein, J. N., Jernigan, T. L., Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Newman, E. R., Kelly, C. A. M., Bjork, J. M., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.01.032 · Cited by 55
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
Schönhofen, P., Bristot, I. J., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018) · CNS Drugs · doi:10.1007/s40263-018-0550-4 · Cited by 58
Cannabinoids in the descending pain modulatory circuit: Role in inflammation
Bouchet, C. A., & Ingram, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107495 · Cited by 53
Molecular and neurocircuitry mechanisms of social avoidance
Gellner, A., Voelter, J., Schmidt, U., Beins, E. C., Stein, V., Philipsen, A., & Hurlemann, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03649-x · Cited by 55
What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
Schulz, P., Hryhorowicz, S., Rychter, A. M., Zawada, A. E., Słomski, R., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2021) · Nutrients · doi:10.3390/nu13020373 · Cited by 54
The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review
James, A. C., James, C., & Thwaites, T. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.07.012 · Cited by 55
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
Edwards, A., & Abizaid, A. B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.032 · Cited by 54
The brain endocannabinoid system in the regulation of energy balance
Richard, D., Guesdon, B., & Timofeeva, E. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.007 · Cited by 56
Cannabinoid modulation of zebrafish fear learning and its functional analysis investigated by c-Fos expression
Ruhl, T., Zeymer, M., & von der Emde, G. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.12.005 · Cited by 48
Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
Sholler, D. J., Huestis, M. A., Amendolara, B., Vandrey, R. G., & Cooper, Z. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173059 · Cited by 50
Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
Fonseca, B. M., & Rebelo, I. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00588-1 · Cited by 48
The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness
Campolongo, P., Ratano, P., Manduca, A., Scattoni, M. L., Palmery, M., Trezza, V., & Cuomo, V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00011 · Cited by 52
Endocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal Level
Bovolin, P., Cottone, E., Pomatto, V., Fasano, S., Pierantoni, R., Cobellis, G., & Meccariello, R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00054 · Cited by 48
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence
Micale, V., Tabiová, K., Kučerová, J., & Drago, F. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_5 · Cited by 47
Segregated Cell Populations Enable Distinct Parallel Encoding within the Radial Axis of the CA1 Pyramidal Layer
Geiller, T., Royer, S., & Choi, J.-S. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.1.1 · Cited by 50
Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells
Galindo, L., Moreno, E., López-Armenta, F., Guinart, D., Cuenca‐Royo, A., Izquierdo-Serra, M., Xicota, L., Fernández-Avilés, C., Menoyo, E., Fernández‐Fernández, J. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0833-7 · Cited by 50
Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma
Nia, A. B., Bender, R. L., & Harpaz‐Rotem, I. (2019) · Chronic Stress · doi:10.1177/2470547019864096 · Cited by 48
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Morris, G., Walder, K. R., Kloiber, S. M., Amminger, G. P., Berk, M., Bortolasci, C. C., Maes, M. H. J., Puri, B. K., & Carvalho, A. F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105729 · Cited by 48
Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin
Russo, C., Lavorgna, M., Nugnes, R., Orlo, E., & Isidori, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01975-z · Cited by 47
Anatomical characterization of the cannabinoid CB1 receptor in cell‐type–specific mutant mouse rescue models
Gutiérrez‐Rodríguez, A., Puente, N., Elezgarai, I., Ruehle, S., Lutz, B., Reguero, L., Gerrikagoitia, I., Marsicano, G., & Grandes, P. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24066 · Cited by 46
An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products
Kitdumrongthum, S., & Trachootham, D. (2023) · Molecules · doi:10.3390/molecules28062791 · Cited by 48
The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 47
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
Crane, N. A., Schuster, R. M., Mermelstein, R. J., & González, R. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1020770 · Cited by 46
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Lu, D., Immadi, S. S., Wu, Z., & Kendall, D. A. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0164-x · Cited by 46
Cerebellar alterations in cannabis users: A systematic review
Blithikioti, C., Miquel, L., Batalla, A., Ballester, B. R., Maffei, G., Herreros, I., Gual, A., Verschure, P. F. M. J., & Balcells‐Oliveró, M. (2019) · Addiction Biology · doi:10.1111/adb.12714 · Cited by 47
Social encounter with a novel partner in adolescent rats: Activation of the central endocannabinoid system
Marco, E. M., Rapino, C., Caprioli, A., Borsini, F., Maccarrone, M., & Laviola, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.044 · Cited by 49
The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
Murillo‐Rodríguez, E., Poot-Aké, A., Arias-Carrión, Ó., Pacheco-Pantoja, E. L., de la Fuente-Ortegon, A., & Arankowsky‐Sandoval, G. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411798047780 · Cited by 47
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Sami, M. B., & Bhattacharyya, S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118760662 · Cited by 45
A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis
Jacobson, M. R., Watts, J. J., Boileau, I., Tong, J., & Mizrahi, R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.014 · Cited by 45
Medical cannabis for chronic pain: can it make a difference in pain management?
Maharajan, M. K., Yong, Y. J., Yip, H. Y., Woon, S. S., Yeap, K. M., Yap, K. Y., Yip, S. C., & Yap, K. X. (2019) · Journal of Anesthesia · doi:10.1007/s00540-019-02680-y · Cited by 46
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Navarro, D., Gasparyan, A., Navarrete, F., Torregrosa, A. B., Rubio, G., Marín, M., Acosta, G. B., García‐Gutiérrez, M. S., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094764 · Cited by 47
Endocannabinoid modulation of male rat sexual behavior
Gorzalka, B. B., Morrish, A. C., & Hill, M. N. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0901-1 · Cited by 45
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2
Morgese, M. G., Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Dipasquale, P., Ferraro, L., Antonelli, T., Cuomo, V., & Giuffrida, A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.007 · Cited by 44

Authors: Mackie, K.
Affiliations: University of Washington (US)
Corresponding author: Mackie, K.
ORCID: Mackie, K.
Venue: Handbook of Experimental Pharmacology
Publisher: Springer-Verlag
Published: 2005-12-23
Issue: 168
Pages: 299-325
DOI: 10.1007/3-540-26573-2_10
OpenAlex: W2149183149
Cited by: 744
References: 103
Citations by year: 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
FWCI: 26.30
Type: book chapter
Language: en
Open access: closed
Locations: Springer eBooks (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
MeSH terms: Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks